Mankind Pharma Financials
NSE: MANKIND | BSE: 543904
₹2,327.90
₹-40.90
(-1.73%)
As on 04-Sep-2026 15:56IST
Market cap
₹96,180 Cr
Revenue (TTM)
₹14,738 Cr
P/E Ratio
47.1
P/B Ratio
5.7
Div. Yield
0 %
Income Statement (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
14,737.88
|
14,277.64
|
12,207.44
|
10,260.44
|
8,749.43
|
7,781.56
|
|
|
|
|
|
|
Total Income
|
15,061.79
|
14,636.43
|
12,744.23
|
10,540.66
|
8,878.00
|
7,977.58
|
|
|
|
|
|
|
Total Expenditure
|
10,911.05
|
10,655.26
|
9,186.97
|
7,745.27
|
6,847.50
|
5,791.01
|
|
|
|
|
|
|
EBITDA
|
3,826.83
|
3,622.38
|
3,020.47
|
2,515.17
|
1,901.93
|
1,990.55
|
|
|
|
|
|
|
Depreciation
|
893.20
|
886.18
|
621.22
|
378.42
|
325.92
|
166.62
|
|
|
|
|
|
|
EBIT
|
2,933.63
|
2,736.20
|
2,399.25
|
2,136.75
|
1,576.01
|
1,823.93
|
|
|
|
|
|
|
Interest
|
578.61
|
644.25
|
431.95
|
34.24
|
45.76
|
59.80
|
|
|
|
|
|
|
Other Income
|
323.91
|
358.79
|
536.79
|
280.22
|
128.57
|
196.03
|
|
|
|
|
|
|
Exceptional Items
|
-129.75
|
-129.75
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Profit before Tax
|
2,549.18
|
2,332.68
|
2,516.33
|
2,397.94
|
1,671.24
|
1,974.60
|
|
|
|
|
|
|
Provision for Tax
|
494.07
|
394.58
|
509.74
|
457.15
|
361.56
|
521.64
|
|
|
|
|
|
|
Profit after Tax
|
2,055.11
|
1,938.10
|
2,006.59
|
1,940.79
|
1,309.68
|
1,452.96
|
|
|
|
|
|
|
Minority Interest
|
-24.90
|
-25.17
|
-20.16
|
-28.87
|
-27.82
|
-19.48
|
|
|
|
|
|
|
Share of Associate
|
12.46
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Consolidated Profit
|
2,042.67
|
1,912.93
|
1,990.96
|
1,912.90
|
1,281.86
|
1,433.48
|
|
|
|
|
|
Liabilities (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
16,300.34
|
16,300.34
|
14,332.39
|
9,363.09
|
7,435.22
|
6,155.23
|
|
|
|
|
|
|
Minority Interest
|
-24.90
|
260.71
|
235.79
|
212.70
|
188.07
|
161.08
|
|
|
|
|
|
|
Non-Current Liabilities
|
5,011.23
|
4,686.53
|
7,419.90
|
187.34
|
199.24
|
168.68
|
|
|
|
|
|
|
Current Liabilities
|
6,507.25
|
6,507.25
|
5,663.56
|
2,119.73
|
1,863.14
|
2,623.46
|
|
|
|
|
|
|
Total Liabilities
|
28,079.53
|
27,754.83
|
27,651.64
|
11,882.86
|
9,685.67
|
9,108.45
|
|
|
|
|
|
Assets (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
20,274.65
|
20,800.63
|
20,663.37
|
5,314.64
|
5,357.80
|
4,701.63
|
|
|
|
|
|
|
Current Assets
|
6,954.20
|
6,951.50
|
6,985.57
|
6,565.52
|
4,324.56
|
4,403.84
|
|
|
|
|
|
|
Total Assets
|
28,079.53
|
27,754.83
|
27,651.64
|
11,882.86
|
9,685.67
|
9,108.45
|
|
|
|
|
|
|
Total Debt*
|
--
|
6,021.78
|
8,300.47
|
196.04
|
162.64
|
868.03
|
|
|
|
|
|
|
Net Current Assets
|
446.95
|
444.25
|
1,322.01
|
4,445.79
|
2,461.42
|
1,780.37
|
|
|
|
|
|
|
Contingent Liabilities
|
--
|
924.77
|
1,019.46
|
89.01
|
47.92
|
82.57
|
|
|
|
|
|
Cashflow (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
3,121.29
|
2,413.38
|
2,152.44
|
1,813.30
|
919.78
|
|
|
|
|
|
|
Cash Flow from Investing Activities
|
--
|
-196.42
|
-12,682.95
|
-2,081.69
|
-1,054.13
|
-1,369.14
|
|
|
|
|
|
|
Cash from Financing Activities
|
--
|
-2,952.69
|
10,232.56
|
5.27
|
-739.73
|
604.62
|
|
|
|
|
|
|
Net Cash Inflow / Outflow
|
--
|
-27.82
|
-37.01
|
76.02
|
19.44
|
155.26
|
|
|
|
|
|
Financials Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
52.04
|
46.34
|
48.25
|
47.75
|
32.00
|
35.78
|
|
|
|
|
|
|
Cash EPS (₹)
|
49.45
|
68.42
|
63.69
|
57.89
|
40.83
|
40.43
|
|
|
|
|
|
|
Adjusted Book Value (₹)
|
407.39
|
393.72
|
346.31
|
233.15
|
185.61
|
153.65
|
|
|
|
|
|
|
Dividend per Share (₹)
|
0.04
|
1.00
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Cash Flow per Share (₹)
|
--
|
75.61
|
58.49
|
53.73
|
45.27
|
22.96
|
|
|
|
|
|
|
Free Cash Flow per Share (₹)
|
--
|
53.10
|
47.28
|
48.23
|
24.22
|
-32.75
|
|
|
|
|
|
Profitability Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
13.24
|
18.32
|
28.35
|
23.49
|
33.96
|
|
|
|
|
|
|
ROE (%)
|
13.60
|
12.69
|
16.98
|
23.14
|
19.27
|
26.72
|
|
|
|
|
|
|
ROA (%)
|
7.36
|
7.00
|
10.15
|
18.00
|
13.94
|
18.83
|
|
|
|
|
|
|
EBIT Margin (%)
|
19.91
|
19.16
|
19.65
|
20.83
|
18.01
|
23.44
|
|
|
|
|
|
|
Net Margin (%)
|
13.64
|
13.24
|
15.75
|
18.41
|
14.75
|
18.21
|
|
|
|
|
|
|
Cash Profit Margin (%)
|
--
|
18.91
|
20.73
|
21.72
|
17.96
|
20.07
|
|
|
|
|
|
Growth Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
14.16
|
16.96
|
18.98
|
17.27
|
12.44
|
25.22
|
|
|
|
|
|
|
EBIT Growth (%)
|
19.45
|
14.04
|
12.29
|
35.58
|
-13.59
|
19.20
|
|
|
|
|
|
|
Net Profit Growth (%)
|
13.50
|
-3.41
|
3.39
|
48.19
|
-9.86
|
12.37
|
|
|
|
|
|
|
EPS Growth (%)
|
6.75
|
-3.97
|
1.05
|
49.22
|
-10.58
|
13.28
|
|
|
|
|
|
|
Book Value Growth (%)
|
--
|
13.74
|
52.99
|
25.62
|
20.79
|
30.35
|
|
|
|
|
|
Valuation Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
47.09
|
43.29
|
50.22
|
48.11
|
--
|
--
|
|
|
|
|
|
|
Price / Book Value
|
5.72
|
5.09
|
7.00
|
9.85
|
--
|
--
|
|
|
|
|
|
|
Dividend Yield (%)
|
0.04
|
0.05
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
EV/EBITDA
|
24.51
|
22.19
|
30.28
|
32.74
|
-0.12
|
0.23
|
|
|
|
|
|
|
Close Price (₹)
|
2,545.60
|
2,005.80
|
2,424.75
|
2,300.75
|
--
|
--
|
|
|
|
|
|
|
High Price (₹)
|
2,726.75
|
2,726.75
|
3,054.80
|
2,374.75
|
--
|
--
|
|
|
|
|
|
|
Low Price (₹)
|
1,909.70
|
1,909.70
|
1,901.05
|
1,080.00
|
--
|
--
|
|
|
|
|
|
|
Market Cap (₹ Cr)
|
96,179.61
|
82,801.75
|
99,978.93
|
92,032.04
|
--
|
--
|
|
|
|
|
|
Solvency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
0.17
|
0.37
|
0.58
|
0.02
|
0.02
|
0.14
|
|
|
|
|
|
|
Short term debt to equity ratio
|
--
|
0.04
|
0.18
|
0.02
|
0.02
|
0.13
|
|
|
|
|
|
|
Current Ratio
|
1.07
|
1.07
|
1.23
|
3.10
|
2.32
|
1.68
|
|
|
|
|
|
|
Quick Ratio
|
0.74
|
0.74
|
0.86
|
2.36
|
1.52
|
1.01
|
|
|
|
|
|
|
Interest Coverage
|
5.41
|
4.62
|
6.83
|
71.03
|
37.52
|
34.02
|
|
|
|
|
|
Operating Efficiency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
11.74
|
12.11
|
12.60
|
8.27
|
6.59
|
4.99
|
|
|
|
|
|
|
Asset Turnover
|
0.53
|
0.54
|
0.64
|
0.99
|
0.97
|
1.05
|
|
|
|
|
|
|
Receivable days
|
--
|
39.93
|
34.35
|
24.35
|
19.33
|
16.25
|
|
|
|
|
|
|
Inventory Days
|
--
|
51.78
|
52.50
|
52.16
|
65.31
|
66.57
|
|
|
|
|
|
|
Payable days
|
--
|
111.46
|
99.93
|
101.86
|
130.57
|
131.38
|
|
|
|
|
|
|
Cash Conversion Cycle
|
--
|
-19.75
|
-13.08
|
-25.35
|
-45.92
|
-48.56
|
|
|
|
|
|
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
